As the ZM008-001 clinical trial progresses, the medical community eagerly awaits the results, which could lead the way for a new era in cancer ... Jun 13
Latest news updates... Oct 26
Latest Pharma News Update... Aug 31
Latest Pharma Update... Aug 23
With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
Significantly improves progression-free Survival vs. Opdivo (nivolumab) in patients... May 22
The antibody is indicated for patients with previously untreated Metastatic or unresectable melanoma... Mar 27
BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
... Dec 18
Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options... Dec 17
... Dec 16
... Dec 11
LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
... Nov 10
FDA approves expanded indication for Merck’s KEYTRUDA (pembrolizumab) in adult patients with relapsed or refractory classical hodgkin lymphoma (cHL) ... Oct 16
... Oct 15
Positive pivotal trial data for the investigational use of PD-1 inhibitor Libtayo® (cemiplimab) in first-line locally advanced or metastatic non-small cell lung ... Sep 21
Major breakthrough for treatment of Nasopharyngeal Carcinomar ... Sep 11
Keytruda would be soon launched in Japan for the treatment of cancerous tumors... Aug 27
Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today declared their 4th and full year report.... Feb 21
-Advertisements-
Friday, June 14, 2024
